Saturday, July 11, 2026

biotech

Dragonboat Biopharmaceutical Company

Dragonboat Biopharmaceutical Company clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
3
Patents
0
Intelligence · Clinical Programs

Dragonboat Biopharmaceutical Company projects

1 ClinicalTrials.gov programs sponsored by Dragonboat Biopharmaceutical Company.

Dragonboat Biopharmaceutical Company has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. anti-EGFR monoclonal antibody

    Dragonboat Biopharmaceutical Company Limited

    Healthy Volunteers

    phase 1 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Dragonboat Biopharmaceutical Company have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.